In June 2014 the Japan Anti-Doping Agency (JADA) has reported an anti-doping rule violation against the Athlete J-4067 (the Athlete) after his sample tested positive for the prohibited substance methylephedrine.
After notification a provisional suspension was ordered and the Athlete filed a statement in his defence.
The Athlete submitted that he had used an over the counter cold medication a week before the competition and without intention to enhance his performance. The Panel concludes that the Athlete’s acted with a certain level of negligence due to he failed to check the ingredients of the medication before using.
Considering the circumstances the Japan Anti-Doping Disciplinary Panel decides on 5 July 2014 to impose a 3 month period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 18 June 2014.
